RECURRENT HIGH-GRADE GLIOMAS

Clinical trials for RECURRENT HIGH-GRADE GLIOMAS explained in plain language.

Never miss a new study

Get alerted when new RECURRENT HIGH-GRADE GLIOMAS trials appear

Sign up with your email to follow new studies for RECURRENT HIGH-GRADE GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immune cells engineered to hunt brain tumors enter first human test

Disease control Recruiting now

This early-phase trial tests a new treatment for adults with glioblastoma or other high-grade gliomas that have come back after standard therapy. The treatment uses specially engineered immune cells (CAR-NK cells) that are designed to target two different markers on tumor cells a…

Matched conditions: RECURRENT HIGH-GRADE GLIOMAS

Phase: PHASE1 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated May 17, 2026 02:54 UTC

RECURRENT HIGH-GRADE GLIOMAS

Get alerted when new RECURRENT HIGH-GRADE GLIOMAS trials appear

Immune cells engineered to hunt brain tumors enter first human test